Update on Alzheimer's Treatment: an interview with Dr. David WeismananwilnerFeb 23, 20231 min readMany thanks to Dr. David Weisman for sharing his insights into lecanemab, the latest FDA approved medication for Alzheimer's disease.Listen here on ReachMD for the full story!https://reachmd.com/programs/neurofrontiers/a-look-at-lecanemab-the-latest-breakthrough-in-alzheimers-treatment/14993/
Many thanks to Dr. David Weisman for sharing his insights into lecanemab, the latest FDA approved medication for Alzheimer's disease.Listen here on ReachMD for the full story!https://reachmd.com/programs/neurofrontiers/a-look-at-lecanemab-the-latest-breakthrough-in-alzheimers-treatment/14993/
Can I pray for you?In this Medscape commentary, Dr. Andrew Wilner explores the ethics of a physician offering to pray for a patient (his wife) after a...
Comments